ORION

Serial Number 86745108
606

Registration Progress

Application Filed
Sep 2, 2015
Under Examination
Feb 9, 2021
Approved for Publication
Dec 15, 2020
Published for Opposition
Dec 15, 2020
Registered

Basic Information

Serial Number
86745108
Filing Date
September 2, 2015
Published for Opposition
December 15, 2020
Abandonment Date
March 14, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 14, 2022
Classes
042

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
675 West Kendall Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Mar 14, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 14, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 9, 2021 EXT1 S SOU EXTENSION 1 FILED
Aug 9, 2021 EX1G S SOU EXTENSION 1 GRANTED
Feb 9, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 15, 2020 PUBO A PUBLISHED FOR OPPOSITION
Dec 15, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2020 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 10, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 10, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 10, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 3, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 26, 2020 ALIE A ASSIGNED TO LIE
Aug 3, 2019 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 9, 2019 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 30, 2018 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 24, 2017 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 22, 2017 ALIE A ASSIGNED TO LIE
May 22, 2017 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 10, 2016 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 6, 2016 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 30, 2016 ALIE A ASSIGNED TO LIE
Oct 13, 2015 CNSL F LETTER OF SUSPENSION MAILED
Oct 11, 2015 CNSL R SUSPENSION LETTER WRITTEN
Oct 10, 2015 DOCK D ASSIGNED TO EXAMINER
Sep 5, 2015 NWAP I NEW APPLICATION ENTERED
Sep 5, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 042
Conducting clinical trials for others in the field of RNAi therapeutics for the treatment of hypercholesterolemia
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042